PRESS RELEASE

Genedata Screener 5.5

Genedata has released Genedata Screener 5.5, its enterprise solution for high throughput and high content screening analysis.

The Screener platform combines enterprise-wide assay data management with high-performance processing workflows and flexible analysis tools. Screener rapidly analyses, integrates and manages all assay data, independent of instrumentation, technology, volume or location. The findings are then combined with chemical, pharmacological and in vivo data to support scientists in the tasks of compound prioritisation and identification of quality lead structures with the highest confidence. 

Screener 5.5 features easy integration of pharmacological fit models and advanced functionality for analyzing experiments with multiple readouts. Users will greatly benefit from the ability to integrate new fit models that are relevant for their particular workflows, such as the Morrison equation for Ki fitting, or new proprietary and public fit algorithms. In addition, the open and scalable architecture extends Screener’s applicability as enterprise screening analysis platform, from uHTS centers to therapeutic areas, and provides access to a wide range of information in corporate research and drug discovery systems.

Company: 
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers